Please select a Capability in order to start your service request.
American Association for Respiratory Care (AARC) Presents Award at Annual CongressDec 9, 2014
LAS VEGAS, Dec. 9, 2014 /PRNewswire/ – CareFusion (NYSE: CFN), a leading global medical technology company, was presented today with the Zenith Award from the American Association for Respiratory Care (AARC) at its International Respiratory Convention and Exhibition being held Dec. 9-12 in Las Vegas.
Voted on by AARC members, the Zenith Award is given to the top corporations in the respiratory care industry and is widely considered the "people's choice" award of the respiratory care profession. Members are asked to evaluate companies that have the most outstanding: Quality of equipment and supplies; Accessibility and helpfulness of sales personnel; Responsiveness; Service record; Truth in advertising; and Support of the respiratory care profession.
"We are honored to receive the Zenith Award, as it not only reflects on the quality of our technology and products, but also on our people who excel at sales and service," said Dan Woolson, vice president and general manager of Respiratory Disposables for CareFusion. "We would like to thank AARC and all of the members who voted for us. We are committed to continue our path to excellence in respiratory care."
In addition, CareFusion is highlighting the following products at this year's AARC Congress in booth 140:
"Through the combination of our ventilation technology, the advanced analytics from our Respiratory Knowledge Portal, our diagnostics, AirLife products, sleep and therapy solutions, CareFusion will showcase our vast portfolio of respiratory solutions at the AARC Congress," said Kevin Ketzel, senior vice president and general manager of the Respiratory business line from CareFusion. "These solutions are focused on improving the safety and reducing the cost of respiratory care for hospitals and across an entire health system."
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.